A MULTIPLE-ONCE DAILY DOSE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE PHARMACOKINETICS AND TOLERABILITY OF ABT-089, A NOVEL NEURONAL NICOTINIC RECEPTOR PARTIAL AGONIST, IN HEALTHY VOLUNTEERS

被引：0
|
作者：
Garimella, Tushar [1 ]
Awni, Walid [1 ]
Yan, Jun [1 ]
Florian, Hana [1 ]
Dutta, Sandeep [1 ]
机构：
[1] Abbott, Global Pharmaceut Res & Dev, Abbott Pk, IL USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2010年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
51
引用
收藏
页码：1068 / 1068
页数：1
相关论文
共 50 条
  • [21] A Double-Blind, Randomised, Placebo-Controlled, Multiple Ascending Dose Study to Investigate Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Zamicastat, in Healthy Male Volunteers
    Magalhaes, L.
    Rocha, F.
    Falcao, A.
    Gama, H.
    Soares-Da-Silva, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [22] Safety and pharmacokinetics of recombinant factor XIII in healthy volunteers - A randomized, placebo-controlled, double-blind, multi-dose study
    Visich, JE
    Zuckerman, LA
    Butine, MD
    Gunewardena, KA
    Wild, R
    Morton, KM
    Reynolds, TC
    THROMBOSIS AND HAEMOSTASIS, 2005, 94 (04) : 802 - 807
  • [23] Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
    Li, Yi
    Toyama, Kaoru
    Nakatsu, Takafumi
    Ishizuka, Hitoshi
    Wu, Hailan
    Cao, Guoying
    Yu, Jicheng
    Wang, Yu
    Liu, Xiaofen
    Guo, Beining
    Wu, Jufang
    Yu, Peimin
    Hong, Zhen
    Zhang, Jing
    Wu, Xiaojie
    ADVANCES IN THERAPY, 2023, 40 (04) : 1628 - 1643
  • [24] Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses of Mirogabalin in Healthy Chinese Participants: A Randomized, Double-Blind, Placebo-Controlled Study
    Yi Li
    Kaoru Toyama
    Takafumi Nakatsu
    Hitoshi Ishizuka
    Hailan Wu
    Guoying Cao
    Jicheng Yu
    Yu Wang
    Xiaofen Liu
    Beining Guo
    Jufang Wu
    Peimin Yu
    Zhen Hong
    Jing Zhang
    Xiaojie Wu
    Advances in Therapy, 2023, 40 (4) : 1628 - 1643
  • [25] A single-center, randomized, placebo-controlled, double-blind study to evaluate the safety, tolerability, and pharmacokinetics of multiple-ascending doses of pridopidine in healthy volunteers
    Osterberg, O.
    Ivkovic, J.
    Sundgreen, C.
    Muglia, P.
    Prang, A.
    Darpo, B.
    NEUROTHERAPEUTICS, 2013, 10 (01) : 175 - 175
  • [26] Tolerability, pharmacokinetics and pharmacodynamics of the once-daily human GLP-1 analog liraglutide in Japanese healthy subjects: a randomized, double-blind, placebo-controlled dose-escalation study
    Irie, S.
    Matsumura, Y.
    Zdravkovic, M.
    Jacobsen, L. V.
    Kageyama, S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (06) : 273 - 279
  • [27] Safety, tolerability, pharmacokinetics and pharmacodynamics of a novel farnesoid X receptor (FXR) agonist-TQA3526 in healthy Chinese volunteers: a double-blind, randomized, placebo-controlled, dose-escalation, food effect phase I study
    Xu, Jia
    Zhang, Hong
    Chen, Hong
    Zhu, Xiaoxue
    Jia, Haiyan
    Xu, Zhongnan
    Huo, Dandan
    Zhang, Hong
    Li, Cuiyun
    Ding, Yanhua
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [28] Tolerability and Pharmacokinetics of Avanafil, a Phosphodiesterase Type 5 Inhibitor: A Single- and Multiple-Dose, Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation Study in Healthy Korean Male Volunteers
    Jung, Jinah
    Choi, Sangmin
    Cho, Sang Heon
    Ghim, Jong-Lyul
    Hwang, Aekyung
    Kim, Unjib
    Kim, Bong Sik
    Koguchi, Atsushi
    Miyoshi, Shinji
    Okabe, Hirotaka
    Bae, Kyun-Seop
    Lim, Hyeong-Seok
    CLINICAL THERAPEUTICS, 2010, 32 (06) : 1178 - 1187
  • [29] Pharmacokinetics and Tolerability of Single Escalating Doses of Gabapentin Enacarbil: A Randomized-Sequence, Double-Blind, Placebo-Controlled Crossover Study in Healthy Volunteers
    Lal, Ritu
    Sukbuntherng, Juthamas
    Luo, Wendy
    Chen, Dan
    Vu, Amanda
    Tovera, James
    Cundy, Kenneth C.
    CLINICAL THERAPEUTICS, 2009, 31 (08) : 1776 - 1786
  • [30] Safety, Tolerability and Pharmacokinetics of FAAH Inhibitor V158866: A Double-Blind, Randomised, Placebo-Controlled Phase I Study in Healthy Volunteers
    Pawsey S.
    Wood M.
    Browne H.
    Donaldson K.
    Christie M.
    Warrington S.
    Drugs in R&D, 2016, 16 (2) : 181 - 191
12345